Cannabinoids increase lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1
This article originally appeared at https://www.sciencedirect.com/science/article/abs/pii/S0006295214004201 Authors Institute of Toxicology and Pharmacology, University of Rostock, Rostock, GermanybSection of Molecular Oncology and Immunotherapy, Department of General Surgery, University of Rostock, Rostock, GermanycDepartment of Radiotherapy and Radiation Oncology, University of Rostock, Rostock, Germany https://doi.org/10.1016/j.bcp.2014.07.014 Abstract Cannabinoids have been shown to promote the expression of the intercellular adhesion […]
Reduction of Benzodiazepine Use in Patients Prescribed Medical Cannabis
This originally appeared at https://www.liebertpub.com/doi/10.1089/can.2018.0020 Authors Chad Purcell Andrew Davis Nico Moolman, and S. Mark Taylor Published Online:23 Sep 2019 https://doi.org/10.1089/can.2018.0020 Abstract Background: Benzodiazepines are a class of medication with sedative properties, commonly used for anxiety and other neurological conditions. These medications are associated with several well-known adverse effects. This observational study aims to investigate the reduction […]
5% of Irish Doctors Regularly Smoke Cannabis
This article originally appeared at https://www.independent.ie/irish-news/health/anonymous-survey-finds-support-among-irish-doctors-for-use-of-cannabis/a826718194.html The Irish Medical Times survey revealed 37pc of doctors have tried cannabis, while a majority, 54pc, support the decriminalisation of small quantities of the drug for personal use. It also showed 8pc of doctors use cannabis — with 5pc using it “regularly”. The anonymous survey involved 89 Irish doctors […]
UK patient secures first NHS reimbursement for cannabis flowers
This article originally appeared at https://cannabishealthnews.co.uk/2023/06/15/zerenia-clinics-uk-patient-first-to-secure-nhs-reimbursement-for-cannabis-flowers/ A patient of Zerenia Clinics UK has made history as the first to secure NHS reimbursement for prescribed cannabis flowers. After a patient from Zerenia Clinics UK was reimbursed by the NHS for their therapy with cannabis-based oral extracts in January 2023, a second patient from the clinic has […]
Cannabis use in patients with fibromyalgia: effect on symptoms relief and health-related quality of life
This originally appeared at https://pubmed.ncbi.nlm.nih.gov/21533029/ Authors Jimena Fiz, Marta Durán, Dolors Capellà, Jordi Carbonell, Magí Farré Abstract Background The aim of this study was to describe the patterns of cannabis use and the associated benefits reported by patients with fibromyalgia (FM) who were consumers of this drug. In addition, the quality of life of FM […]
Multiple Sclerosis and Use of Medical Cannabis: A Retrospective Review of a Neurology Outpatient Population
This article originally appeared at https://pubmed.ncbi.nlm.nih.gov/37250194/ Authors Michelle M. Rainka, PharmD; Traci S. Aladeen, PharmD; Anna G. Mattle, PharmD, MS; Emily Lewandowski, PharmD; Denis Vanini, PharmD; Katelyn McCormack, NP; Laszlo Mechtler, MD Int J MS Care (2023) 25 (3): 111–117. https://doi.org/10.7224/1537-2073.2022-006 ABSTRACT BACKGROUND Patients diagnosed as having multiple sclerosis (MS) experience a wide range of […]
Cannabidiol as an adjuvant treatment in adults with drug-resistant focal epilepsy
This article originally appeared at https://pubmed.ncbi.nlm.nih.gov/37196452/ Authors Silvia Kochen 1 , Manuela Villanueva 1 , Liliana Bayarres 1 , Anilu Daza-Restrepo 1 , Silvia Gonzalez Martinez 1 , Silvia Oddo 2 Highlights Abstract Cannabidiol oil (CBD) has been approved as an anti-seizure medication for the treatment of uncommon types of epilepsy, occurring in children: Dravet syndrome, Lennox-Gastaut syndrome, and Tuberous […]
Neurodevelopmental outcomes in children after prenatal marijuana exposure
This article originally appeared at https://pubmed.ncbi.nlm.nih.gov/37283466/ Authors Oliver G Isik 1 , Ling Guo 1 , Andrew J O Whitehouse 2 , Guohua Li 1 3 , Caleb Ing 1 3 Abstract Background: The effect of prenatal marijuana exposure (PME) on child neurodevelopment remains poorly understood. Prior studies have demonstrated inconsistent results. Objectives: This study evaluated the […]
The Safety and Comparative Effectiveness of Non-Psychoactive Cannabinoid Formulations for the Improvement of Sleep
The Safety and Comparative Effectiveness of Non-Psychoactive Cannabinoid Formulations for the Improvement of Sleep: A Double-Blinded, Randomized Controlled Trial Jessica Londeree Saleska, Corey Bryant, Antonija Kolobaric, Christopher R. D’Adamo, Christopher S. Colwell, Derek Loewy Received 24 Feb 2023, Accepted 11 Apr 2023, Published online: 10 May 2023 https://doi.org/10.1080/27697061.2023.2203221 This originally appeared at https://www.tandfonline.com/doi/full/10.1080/27697061.2023.2203221 Abstract Background […]
Earmarking Excise Taxes on Recreational Cannabis for Investmentsin Mental Health
This originally appeared at https://jamanetwork.com/journals/jama-health-forum/fullarticle/2790754 What Are Excise and Earmarked Taxes, and When Are They Appropriate? An excise tax is a tax imposed on a specific good or activity, like tobacco or indoor tanning. An earmarked tax is a tax for which revenue is dedicated for a specific purpose.6 There is generally consensus among tax […]
